Outlook Therapeutics announces $5M registered direct offering priced at-the-market
Summary
Outlook Therapeutics (OTLK) announces a $5M registered direct offering at $0.31 plus warrants; closing expected Apr 23, 2026.
Description
Outlook Therapeutics (OTLK) announces a $5M registered direct offering at $0.31 plus warrants; closing expected Apr 23, 2026.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source